ArticleCureus2024
Supply-Side Barriers in Accessing Human Papillomavirus Screening for Cervical Cancer Prevention in Rural India: Evidence From a Cross-Sectional Study.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Demand-side barriers and economic burden in accessing Human Papillomavirus screening for cervical cancer prevention in rural India: Evidence from a cross-sectional study.F1000Research · 2024Article
- Integrating Cervical Cancer Screening into Rural Healthcare Delivery Systems for Better Patient Outcomes.Journal of mid-life healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCervical cancer is a leading cause of cancer-related mortality among women worldwide, particularly in low- and middle-income countries. In India, rural areas face a disproportionate burden of cervical cancer cases. Effective screening methods, such as Human Papillomavirus (HPV) testing, are recommended by the World Health Organization (WHO) for early detection and prevention. However, the uptake of these screening methods in rural India is significantly low due to various supply-side barriers. This study aims to evaluate the readiness and capacity of PHCs in rural India to conduct HPV screening tests. MATERIALS AND
methodsThis cross-sectional study in Pondicherry, India, examined cervical cancer screening and management at 15 primary health centers (PHCs) through a structured questionnaire. It assessed personnel training for HPV screening, availability of screening tests, healthcare infrastructure functionality, supply chain efficiency, infection prevention practices, medicine and diagnostic supply availability, referral protocols, data management practices, policy adherence, and equipment availability.
resultsVisual inspection with acetic acid was available in all PHCs, while more advanced tests like cytology, HPV testing, loop electrosurgical excision procedure (LEEP), colposcopy, and histology/pathology were generally absent. Only one PHC had personnel trained for cytology processing, with none trained for other advanced procedures or HPV testing. The study identified significant gaps in healthcare infrastructure, trained personnel, and supply chain logistics.
conclusionEnhancing cervical cancer screening and treatment in PHCs necessitates investments in infrastructure, training, and data systems. Key priorities include upgrading equipment like colposcopes and implementing a robust Health Management Information System (HMIS). Collaboration with stakeholders is essential for effective resource allocation and capacity building.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.